DIASORIN (Germany) Performance
| 34D Stock | EUR 68.44 0.00 0.00% |
The firm owns a Beta (Systematic Risk) of -0.53, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning DIASORIN are expected to decrease at a much lower rate. During the bear market, DIASORIN is likely to outperform the market. At this point, DIASORIN has a negative expected return of -0.19%. Please make sure to confirm DIASORIN's market risk adjusted performance, coefficient of variation, variance, as well as the relationship between the mean deviation and standard deviation , to decide if DIASORIN performance from the past will be repeated at some future date.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days DIASORIN has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
| Begin Period Cash Flow | 339.9 M | |
| Free Cash Flow | 283.3 M |
DIASORIN |
DIASORIN Relative Risk vs. Return Landscape
If you would invest 7,800 in DIASORIN on October 10, 2025 and sell it today you would lose (956.00) from holding DIASORIN or give up 12.26% of portfolio value over 90 days. DIASORIN is producing return of less than zero assuming 2.5349% volatility of returns over the 90 days investment horizon. Simply put, 22% of all stocks have less volatile historical return distribution than DIASORIN, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
DIASORIN Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DIASORIN's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DIASORIN, and traders can use it to determine the average amount a DIASORIN's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0743
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 34D |
Estimated Market Risk
| 2.53 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average DIASORIN is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DIASORIN by adding DIASORIN to a well-diversified portfolio.
DIASORIN Fundamentals Growth
DIASORIN Stock prices reflect investors' perceptions of the future prospects and financial health of DIASORIN, and DIASORIN fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DIASORIN Stock performance.
| Current Valuation | 8.21 B | |||
| Price To Book | 4.51 X | |||
| Price To Sales | 5.18 X | |||
| Revenue | 1.24 B | |||
| EBITDA | 517.3 M | |||
| Total Debt | 1.23 B | |||
| Cash Flow From Operations | 400.66 M | |||
| Total Asset | 3.23 B | |||
About DIASORIN Performance
By analyzing DIASORIN's fundamental ratios, stakeholders can gain valuable insights into DIASORIN's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DIASORIN has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DIASORIN has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about DIASORIN performance evaluation
Checking the ongoing alerts about DIASORIN for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DIASORIN help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DIASORIN generated a negative expected return over the last 90 days |
- Analyzing DIASORIN's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DIASORIN's stock is overvalued or undervalued compared to its peers.
- Examining DIASORIN's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DIASORIN's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DIASORIN's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DIASORIN's stock. These opinions can provide insight into DIASORIN's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DIASORIN Stock analysis
When running DIASORIN's price analysis, check to measure DIASORIN's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DIASORIN is operating at the current time. Most of DIASORIN's value examination focuses on studying past and present price action to predict the probability of DIASORIN's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DIASORIN's price. Additionally, you may evaluate how the addition of DIASORIN to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |